Your browser doesn't support javascript.
loading
Efficacy Observation of Amlodipine Besylate Combined with Xinkeshu in the Treatment of Hypertension / 中国药房
China Pharmacy ; (12): 2054-2055,2056, 2016.
Artículo en Chino | WPRIM | ID: wpr-605672
ABSTRACT

OBJECTIVE:

To observe the efficacy and safety of amlodipine besylate combined with Xinkeshu in the treatment of hypertension.

METHODS:

100 patients with hypertension were randomly divided into control group (50 cases) and observation group(50 cases). Control group was orally given one Amlodipine besylate tablet,once a day;observation group was additionally given 4 Xinkeshu tablets,3 times a day. The treatment course was 8 weeks. Clinical efficacy,systolic blood pressure(SBP)and di-astolic blood pressure(DBP)before and after treatment in 2 groups were observed,the incidence of adverse reactions was record-ed.

RESULTS:

The total effective rate in observation group was significantly higher than control group,the incidence of adverse re-actions was significantly lower than control group,the differences were statistically significant (P0.05). After treatment,the SBP and DBP in 2 groups were significantly lower than before,the differences were statistically significant(P0.05).

CONCLUSIONS:

The efficacy of amlodipine besylate combined with Xinkeshu is superior to amlo-dipine besylate alone in the treatment of hypertension,with better safety.

Texto completo: Disponible Índice: WPRIM (Pacífico Occidental) Idioma: Chino Revista: China Pharmacy Año: 2016 Tipo del documento: Artículo

Similares

MEDLINE

...
LILACS

LIS

Texto completo: Disponible Índice: WPRIM (Pacífico Occidental) Idioma: Chino Revista: China Pharmacy Año: 2016 Tipo del documento: Artículo